Business
Kootenay Silver Announces Upsize of Bought Deal Public Offering to $17.4 Million
The Base Shelf Prospectus is accessible, and the Prospectus Supplement will be accessible within ...
About this update from Kootenay Silver Inc.
[{"type":"text","content":"Kootenay Silver Announces Upsize of Bought Deal Public Offering to $17.4 MillionThe Base Shelf Prospectus is accessible, and the Prospectus Supplement will be accessible within one business day, through SEDAR+Vancouver, British Columbia--(Newsfile Corp. - June 18, 2025) - Kootenay Silver Inc. (TSXV: KTN) (OTCQX: KOOYF) (the \"Company\" or \"Kootenay\") is pleased to announce that, due to strong investor demand, it has entered into an amended agreement with Research Capital Corporation as the lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters (collectively, the \"Underwriters\"), to increase the size of its previously announced \"bought deal\" public offering, pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 16,572,000 units of the Company (the \"Units\") at a price of $1.05 per Unit for aggregate gross proceeds to the Company of $17,400,600 (the \"Offering\"). Each Unit shall be comprised of one common share of the Company (a \"Common Share\") and one-half of one Common Share purchase warrant of the Company (each whole warrant, a \"Warrant\"). Each Warrant shall entitle the holder thereof to purchase one Common Share at an exercise price of $1.58 per Common Share for a period of 36 months following closing of the Offering. The net proceeds from the Offering of the Units will be used for advancement of the Company's Columba Silver Project in Mexico, working capital and general corporate purposes.The Company has granted to the Underwriters an option (the \"Over-Allotment Option\") to increase the size of the Offering by up to an additional number of Units, and/or the components thereof, that in aggregate would be equal to 15% of the total number of Units to be issued under the Offering, to cover over-allotments, if any, and for market stabilization purposes, exercisable at any time and from time to time up to 30 days following the closing of the Offering.The closing of the Offering is expected to occur on or about June 25, 2025 (the \"Closing\"), or such other earlier or later date as the Underwriters may determine. Closing is subject to the Company receiving all necessary regulatory approvals, including the approval of the TSX Venture Exchange (the \"Exchange\") to list, on the date of Closing, the Common Shares, and the Common Shares issuable upon exercise of the War...